Implementation Feasibility and Clinical Utility of Phenomapping in Dilated and Hypokinetic Non-dilated Non-ischemic Cardiomyopathy

Aims Despite phenotypic heterogeneity, the management of idiopathic non-ischemic cardiomyopathy (NICM) remains generalized and dominantly guided by left ventricular (LV) ejection fraction (EF) and NYHA class. We aimed to develop a point-of-service phenomapping pathway for dilated cardiomyopathy (DCM) and hypokinetic non-dilated cardiomyopathy (HNDC) at time of CMR imaging leveraging the integration of i) patient self-reported health status, ii) imaging phenotype, and the iii) electronic health record (EHR). Methods and results 1,355 patients (752 DCM and 603 HNDC) were followed for the composite MACE outcome of mortality, heart failure hospitalization or ventricular arrhythmia. K-means clustering was independently applied to DCM and HNDC derivation cohorts using 55 routinely captured features (16 patient-reported health variables, 19 CMR-derived, 14 EHR-derived, and 6 combined features), identifying three phenogroups in each cohort. Over a median of 3.9 and 3.7 years, 145 DCM patients (22%) and 65 HNDC patients (13%), respectively, experienced MACE. Adjusting for age, sex, NYHA class, and LV EF, phenogroup membership was independently associated with future outcomes. In DCM, the adjusted HR (95% CI) of phenogroups 2 and 3 versus Phenogroup 1 were 2.8 (1.6-4.8) and 3.5 (1.9-6.5), respectively (p<0.001 for both). In HNDC, Phenogroup 3 demonstrated an adjusted HR of 4.2 (1.7-10.2; p=0.001) versus Phenogroup 1. Prospective phenogroup assignment was enabled by a decision tree-classifier and validated in a temporal hold-out cohort. Conclusion Phenomapping delivers incremental value to LVEF and NYHA for identification of high-risk NICM patients. These findings support value from standardized, point-of-service data integration for the delivery of phenomics-driven personalized care.

Authors

Institutions

Publication Details

Journal
European Heart Journal - Cardiovascular Imaging
Published
2026-11-19
DOI
https://doi.org/10.1093/ehjci/jeag329
Primary Topic
Cardiomyopathy and Myosin Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Implementation Feasibility and Clinical Utility of Phenomapping in Dilated and Hypokinetic Non-dilated Non-ischemic Cardiomyopathy

Justin J. Tse, Nowell Mark Fine, Sandra M. Rivest, Steven Dykstra et al.
European Heart Journal - Cardiovascular Imaging
Cardiomyopathy and Myosin Studies
article

Implementation Feasibility and Clinical Utility of Phenomapping in Dilated and Hypokinetic Non-dilated Non-ischemic Cardiomyopathy

Justin J. Tse, Nowell Mark Fine, Sandra M. Rivest, Steven Dykstra, Carmen P. Lydell, Ahmed Abdelhaleem, Fereshteh Hasanzadeh, Andrew G. Howarth, Louis R. Kolman, James A. White, Jacqueline A. Flewitt, Dina Labib, Yifan Wang, R J H Miller, Yuanchao Feng
article en

Abstract

Aims Despite phenotypic heterogeneity, the management of idiopathic non-ischemic cardiomyopathy (NICM) remains generalized and dominantly guided by left ventricular (LV) ejection fraction (EF) and NYHA class. We aimed to develop a point-of-service phenomapping pathway for dilated cardiomyopathy (DCM) and hypokinetic non-dilated cardiomyopathy (HNDC) at time of CMR imaging leveraging the integration of i) patient self-reported health status, ii) imaging phenotype, and the iii) electronic health record (EHR). Methods and results 1,355 patients (752 DCM and 603 HNDC) were followed for the composite MACE outcome of mortality, heart failure hospitalization or ventricular arrhythmia. K-means clustering was independently applied to DCM and HNDC derivation cohorts using 55 routinely captured features (16 patient-reported health variables, 19 CMR-derived, 14 EHR-derived, and 6 combined features), identifying three phenogroups in each cohort. Over a median of 3.9 and 3.7 years, 145 DCM patients (22%) and 65 HNDC patients (13%), respectively, experienced MACE. Adjusting for age, sex, NYHA class, and LV EF, phenogroup membership was independently associated with future outcomes. In DCM, the adjusted HR (95% CI) of phenogroups 2 and 3 versus Phenogroup 1 were 2.8 (1.6-4.8) and 3.5 (1.9-6.5), respectively (p<0.001 for both). In HNDC, Phenogroup 3 demonstrated an adjusted HR of 4.2 (1.7-10.2; p=0.001) versus Phenogroup 1. Prospective phenogroup assignment was enabled by a decision tree-classifier and validated in a temporal hold-out cohort. Conclusion Phenomapping delivers incremental value to LVEF and NYHA for identification of high-risk NICM patients. These findings support value from standardized, point-of-service data integration for the delivery of phenomics-driven personalized care.

European Heart Journal - Cardiovascular Imaging
Alberta Health Services (CA), Cairo University (EG), University of Ottawa (CA), University of Calgary (CA), Cairo University hospitals (EG), Saint Alphonsus Medical Center (US), Libin Cardiovascular Institute of Alberta (CA)
Cardiomyopathy and Myosin Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon